{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T05:56:29Z","timestamp":1780466189147,"version":"3.54.1"},"reference-count":22,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2011,2,1]],"date-time":"2011-02-01T00:00:00Z","timestamp":1296518400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,2,1]],"date-time":"2011-02-01T00:00:00Z","timestamp":1296518400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinical-lymphoma-myeloma-leukemia.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Lymphoma Myeloma and Leukemia"],"published-print":{"date-parts":[[2011,2]]},"DOI":"10.3816\/clml.2011.n.037","type":"journal-article","created":{"date-parts":[[2012,11,13]],"date-time":"2012-11-13T15:18:45Z","timestamp":1352819925000},"page":"157-159","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Pathogenesis and Morbidity of Autoantibody Syndromes in Waldenstrom's Macroglobulinemia"],"prefix":"10.3816","volume":"11","author":[{"given":"Marvin J.","family":"Stone","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.3816\/CLML.2011.n.037_bib1","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1101\/SQB.1967.032.01.013","article-title":"The valence of a Waldenstr\u00f6m macroglobulin antibody and further thoughts on the significance of paraprotein antibodies","volume":"32","author":"Stone","year":"1967","journal-title":"Cold Spring Harbor Sympos Quant Biol"},{"key":"10.3816\/CLML.2011.n.037_bib2","article-title":"Waldenstr\u00f6m's macroglobulinemia. Encyclopedic reference of molecular mechanisms of disease","author":"Stone","year":"2008","journal-title":"Springer-Verlag"},{"key":"10.3816\/CLML.2011.n.037_bib3","doi-asserted-by":"crossref","first-page":"225","DOI":"10.3816\/CLM.2005.n.004","article-title":"Autoantibody activity in Waldenstr\u00f6m's macroglobulinemia","volume":"5","author":"Stone","year":"2005","journal-title":"Clin Lymphoma"},{"key":"10.3816\/CLML.2011.n.037_bib4","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1182\/blood-2007-05-090654","article-title":"Accurate identification of paraprotein antigen targets by epitope reconstruction","volume":"111","author":"Sompuram","year":"2008","journal-title":"Blood"},{"key":"10.3816\/CLML.2011.n.037_bib5","article-title":"Identification of antigenic determinants in WM","author":"Bogen","year":"2010","journal-title":"Clinical Lymphoma Myeloma Leuk"},{"key":"10.3816\/CLML.2011.n.037_bib6","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1053\/sonc.2003.50082","article-title":"Clinicopathological definition of Waldenstrom's macroglobulinemia: consensus panel recommendations from the second international workshop on Waldenstrom's macroglobulinemia","volume":"30","author":"Owen","year":"2003","journal-title":"Semin in Oncology"},{"key":"10.3816\/CLML.2011.n.037_bib7","first-page":"217","article-title":"Incipient myelomatosis or \u2018essential' hyperglobulinemia with fibrinogenopenia a new syndrome","volume":"CXVII","author":"Waldenstr\u00f6m","year":"1944","journal-title":"Acta Medica Scandinavia"},{"key":"10.3816\/CLML.2011.n.037_bib8","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.4049\/jimmunol.113.4.1377","article-title":"Studies on monoclonal antibodies. II immune complex (IgM-IgG) cryoglobulinemia: the mechanism of cryoprecipitation","volume":"113","author":"Stone","year":"1974","journal-title":"J Immunol"},{"key":"10.3816\/CLML.2011.n.037_bib9","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1053\/sonc.2003.50077","article-title":"Human monoclonal macroglobulins with antibody activity","volume":"30","author":"Stone","year":"2003","journal-title":"Semin Oncol"},{"key":"10.3816\/CLML.2011.n.037_bib10","doi-asserted-by":"crossref","first-page":"97","DOI":"10.3816\/CLM.2009.n.026","article-title":"Waldenstr\u00f6m's macroglobulinemia: hyperviscosity syndrome and cryoglobulinemia","volume":"9","author":"Stone","year":"2009","journal-title":"Clin Lymphoma Myeloma"},{"key":"10.3816\/CLML.2011.n.037_bib11","doi-asserted-by":"crossref","first-page":"359","DOI":"10.3324\/haematol.2009.017251","article-title":"Pathophysiology of Waldenstr\u00f6m's macroglobulinemia","volume":"95","author":"Stone","year":"2010","journal-title":"Haematologica"},{"key":"10.3816\/CLML.2011.n.037_bib12","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1038\/ki.2009.247","article-title":"Hepatitis-c virus-induced cryoglobulinemia","volume":"76","author":"Charles","year":"2009","journal-title":"Kidney International"},{"key":"10.3816\/CLML.2011.n.037_bib13","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1182\/blood-2009-10-248518","article-title":"Rituximab plus Peg-interferon-\u03b1\/ribavirin compared with Peg-interferon-\u03b1\/ribavirin in hepatitis C-related mixed cryoglobulinemia","volume":"116","author":"Saadoun","year":"2010","journal-title":"Blood"},{"key":"10.3816\/CLML.2011.n.037_bib14","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1182\/blood-2009-11-253948","article-title":"Safety and efficacy of rituximab in patients with hepatitis C virus-related mixed cryoglobulinemia and severe liver disease","volume":"116","author":"Petrarca","year":"2010","journal-title":"Blood"},{"key":"10.3816\/CLML.2011.n.037_bib15","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1182\/blood-2009-10-245878","article-title":"Pegylated interferon-\u03b1, ribavirin, and rituximab combined therapy of hepatitis C virus-related mixed cryoglobulinemia: a long-term study","volume":"116","author":"Dammacco","year":"2010","journal-title":"Blood"},{"key":"10.3816\/CLML.2011.n.037_bib16","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/j.1365-2141.1957.tb05782.x","article-title":"Serum proteins in acquired hemolytic anemia (auto-antibody type)","volume":"3","author":"Christenson","year":"1957","journal-title":"Br J Haematol"},{"key":"10.3816\/CLML.2011.n.037_bib17","first-page":"110","article-title":"Cold-agglutinin-mediated autoimmune hemolytic anemia in Waldenstrom's macroglobulinemia","author":"Berensten","year":"2009","journal-title":"Clin Lymphoma Myeloma"},{"key":"10.3816\/CLML.2011.n.037_bib18","doi-asserted-by":"crossref","first-page":"3119","DOI":"10.1182\/blood-2010-07-297523","article-title":"Inside Blood: Heating up cold agglutinins","volume":"116","author":"Stone","year":"2010","journal-title":"Blood"},{"key":"10.3816\/CLML.2011.n.037_bib19","doi-asserted-by":"crossref","first-page":"3180","DOI":"10.1182\/blood-2010-06-288647","article-title":"High response rate and durable remissions following fludarabine and rituximab combination therapy for chronic cold agglutinin disease","volume":"116","author":"Berentsen","year":"2010","journal-title":"Blood"},{"key":"10.3816\/CLML.2011.n.037_bib20","doi-asserted-by":"crossref","first-page":"107","DOI":"10.3816\/CLM.2009.n.029","article-title":"Antigenic determinants in IgM paraprotein-related neuropathies","volume":"9","author":"Nobile-Orazio","year":"2009","journal-title":"Clin Lymphoma Myeloma"},{"key":"10.3816\/CLML.2011.n.037_bib21","article-title":"Antigenic determinants in IgM related neuropathies","author":"Nobile-Orazio","year":"2010","journal-title":"Clin Lymphoma Myeloma"},{"key":"10.3816\/CLML.2011.n.037_bib22","doi-asserted-by":"crossref","first-page":"2520","DOI":"10.1182\/blood-2006-03-001164","article-title":"Review in translational hematology: dangerous small B-cell clones","volume":"108","author":"Merlini","year":"2006","journal-title":"Blood"}],"container-title":["Clinical Lymphoma Myeloma and Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265011701586?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265011701586?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:25:03Z","timestamp":1761870303000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2152265011701586"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,2]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,2]]}},"alternative-id":["S2152265011701586"],"URL":"https:\/\/doi.org\/10.3816\/clml.2011.n.037","relation":{},"ISSN":["2152-2650"],"issn-type":[{"value":"2152-2650","type":"print"}],"subject":[],"published":{"date-parts":[[2011,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pathogenesis and Morbidity of Autoantibody Syndromes in Waldenstrom's Macroglobulinemia","name":"articletitle","label":"Article Title"},{"value":"Clinical Lymphoma Myeloma and Leukemia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.3816\/CLML.2011.n.037","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}